Zobrazeno 1 - 10
of 107
pro vyhledávání: '"R. Brizzolara"'
Publikováno v:
Reumatismo, Vol 67, Iss 1, Pp 29-32 (2015)
This study was aimed to standardize the technique for counting monosodium urate (MSU) crystals in the synovial fluid (SF) of patients with gout. A total of 52 SF specimens were examined under a polarized light microscope. The amount of SF ranged betw
Externí odkaz:
https://doaj.org/article/47d02d4137f145fbad9a65f69fb87190
Autor:
B. Villaggio, B. Seriolo, A. Sulli, A. Parodio, C. Ferrone, R. Brizzolara, P. Montagna, S. Soldano, M. Cutolo
Publikováno v:
Reumatismo, Vol 64, Iss 5, Pp 326-334 (2012)
Endothelin-1 (ET-1) seems to enhance the pro-fibrotic protein synthesis by skin fibroblasts and its effects are mediated by endothelin-A and B (ETA and ETB) receptors. This study aimed to investigate the effects of ETA and ETB receptor antagonists (E
Externí odkaz:
https://doaj.org/article/e244409e28f044feac4beabf8afaf13a
Autor:
L. Felli, L. Molfetta, P. Clerico, P.F. Triolo, B. Villaggio, B. Seriolo, A. Sulli, P. Montagna, S. Soldano, R. Brizzolara, M. Cutolo
Publikováno v:
Reumatismo, Vol 63, Iss 2, Pp 80-85 (2011)
Objective: CTLA4-Ig, a biologic agent employed in rheumatoid arthritis (RA) treatment, downregulates the immune response and exerts anti-inflammatory effects acting on different cells including dendritic/T cells interaction and directly on osteoclast
Externí odkaz:
https://doaj.org/article/305e711f112d44aba16a49cc4d0aeb08
Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
Publikováno v:
Journal of Biological Research, Vol 84, Iss 1 (2011)
The present study evaluated the effects of a non-selective endothelin (ETA/B) receptors antagonist, on collagen type I (COLI) synthesis on in vitro culture of scleroderma (SSc) skin fibroblasts (Fb). Fb were obtained from skin biopsies of 6 female SS
Externí odkaz:
https://doaj.org/article/13db71553aff42bcad923186f72d249c
Autor:
A, Picciotto, F, Torre, R, Brizzolara, N, Campo, R, Giusto, N, Sinelli, B P, Lantieri, D, Risso, G, Celle
Publikováno v:
Minerva gastroenterologica e dietologica. 45(3)
Aim of this work was to evaluate the early viral decay induced by a daily therapy with alfa-interferon (IFN) and the presence of any synergistic effects of amantadine and ribavirin.Twenty patients with a diagnosis of chronic hepatitis C were randomly
Autor:
C, Salmaso, M, Bagnasco, G, Pesce, P, Montagna, R, Brizzolara, V, Altrinetti, P, Richiusa, A, Galluzzo, C, Giordano
Publikováno v:
Annals of the New York Academy of Sciences. 966
Dysregulation of apoptosis is associated with the pathogenesis of organ-specific autoimmune diseases, through altered target organ susceptibility. Apoptosis signaling pathways can be initiated through activation of death receptors such as Fas. A comp
Autor:
F, Puppo, F, Torre, P, Contini, M, Ghio, S, Brenci, R, Brizzolara, N, Sinelli, N, Campo, F, Indiveri, A, Picciotto
Publikováno v:
Journal of clinical immunology. 20(6)
The serum levels of soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chains were determined in 28 interferon-alpha nonresponder chronic hepatitis C patients retreated with interferon-alpha plus ribavirin and in 70 healthy subjects. The
Publikováno v:
Hepato-gastroenterology. 47(35)
To evaluate the HGV infection prevalence in a group of intravenous drug users with or without human immunodeficiency virus coinfection.We studied 57 patients (48 males and 9 females) who were either previous or still ongoing intravenous drug users. T
Autor:
A, Picciotto, N, Campo, R, Brizzolara, N, Sinelli, F, Torre, A G, Cipriani, I, Ponassi, G, Varagona, A, Grasso, P, De Leo, V, De Conca, S, Mesiti, G, Marenco, G, Menardo, M, Dodero, G, Celle
Publikováno v:
European journal of gastroenterologyhepatology. 11(6)
OBJECTIVE; To evaluate the results of a large cohort of non-responder or relapsing responder patients with chronic hepatitis C retreated with various schedules of interferon (IFN).Our study included 276 patients (158 non-responders and 118 relapsing
Publikováno v:
EDTNA/ERCA journal (English ed.). 24(3)
Haemodialysis patients are at high risk of developing liver disease due to blood-borne viral agents. At present hepatitis C virus (HCV) is the most common cause of infection in these patients. A new RNA virus of the Flaviviridae family, hepatitis G v